close

ICON plc, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in the United States, Ireland, and rest of Europe. It specializes in strategic development, management, and analysis of programs that support clinical development from compound selection to Phase I to IV clinical studies. The company's clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, patient safety monitoring, clinical data management, interactive voice response, medical reporting, patient registries, outcomes research, and health economics. Its clinical research services also comprise strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, medical imaging, and contract staffing. In addition, the company provides various laboratory services, including sample analysis, safety testing, microbiology, custom flow cytometry, and electronic transmission of test results. ICON plc was founded in 1990 and is headquartered in Dublin, Ireland.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	21.80
Volume	168714
Volume Avg	196342
52 Week High	26.22
52 Week Low	15.03
PE	59.46
PE (group average)	39
EPS Year	0.37
EPS change Q/Q	-62.16%
EPS change Q/Q Yr ago	-63.16%
EPS change Q/Q next Q est	-36.36%
EPS change Y/Y	34.43%
REV change Q/Q	-1.21%
REV change Q/Q Yr ago	4.66%
EPS next Q est	0.22
EPS next Y est	1.49
Divident Annual	0.00
Dividend Yield	0%